These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23179879)

  • 1. Non-peptidyl (18)F-labelled PET tracers as radioindicators for the noninvasive detection of cancer.
    Wagner S; Kopka K
    Recent Results Cancer Res; 2013; 187():107-32. PubMed ID: 23179879
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Waldmann CM; Kopka K; Wagner S
    Recent Results Cancer Res; 2020; 216():283-318. PubMed ID: 32594390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (18)F-labelled cardiac PET tracers: selected probes for the molecular imaging of transporters, receptors and proteases.
    Kopka K; Schober O; Wagner S
    Basic Res Cardiol; 2008 Mar; 103(2):131-43. PubMed ID: 18324369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncologic PET tracers beyond [(18)F]FDG and the novel quantitative approaches in PET imaging.
    Kumar R; Dhanpathi H; Basu S; Rubello D; Fanti S; Alavi A
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):50-65. PubMed ID: 18235421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorinated tracers for imaging cancer with positron emission tomography.
    Couturier O; Luxen A; Chatal JF; Vuillez JP; Rigo P; Hustinx R
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1182-206. PubMed ID: 15241631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tracers in oncology - preclinical and clinical evaluation].
    Krause BJ; Schwarzenböck S; Schwaiger M
    Nuklearmedizin; 2010; 49 Suppl 1():S41-5. PubMed ID: 21152689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography.
    Dollé F
    J Labelled Comp Radiopharm; 2013; 56(3-4):65-7. PubMed ID: 24285311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments in PET for the detection of endocrine tumours.
    Eriksson B; Orlefors H; Oberg K; Sundin A; Bergström M; Långström B
    Best Pract Res Clin Endocrinol Metab; 2005 Jun; 19(2):311-24. PubMed ID: 15763703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biodistribution of an 18F-labelled resveratrol derivative for small animal positron emission tomography.
    Gester S; Wuest F; Pawelke B; Bergmann R; Pietzsch J
    Amino Acids; 2005 Dec; 29(4):415-28. PubMed ID: 15997411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 18F-labelled cyclooxygenase-2 (COX-2) inhibitors via Stille reaction with 4-[18F]fluoroiodobenzene as radiotracers for positron emission tomography (PET).
    Wüst FR; Höhne A; Metz P
    Org Biomol Chem; 2005 Feb; 3(3):503-7. PubMed ID: 15678189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non FDG PET.
    Nanni C; Fantini L; Nicolini S; Fanti S
    Clin Radiol; 2010 Jul; 65(7):536-48. PubMed ID: 20541653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrazoles as Key Scaffolds for the Development of Fluorine-18-Labeled Radiotracers for Positron Emission Tomography (PET).
    Gomes PMO; Silva AMS; Silva VLM
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32283680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorine-18 Labelled Radioligands for PET Imaging of Cyclooxygenase-2.
    Kaur J; Bhardwaj A; Wuest F
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PET-CT in the oncological translational platforms].
    Carreras Delgado JL
    An R Acad Nac Med (Madr); 2010; 127(3):435-42; discussion 442-4. PubMed ID: 22263341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammary cancer bone metastasis follow-up using multimodal small-animal MR and PET imaging.
    Doré-Savard L; Barrière DA; Midavaine É; Bélanger D; Beaudet N; Tremblay L; Beaudoin JF; Turcotte EE; Lecomte R; Lepage M; Sarret P
    J Nucl Med; 2013 Jun; 54(6):944-52. PubMed ID: 23596003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new?
    Vallabhajosula S; Solnes L; Vallabhajosula B
    Semin Nucl Med; 2011 Jul; 41(4):246-64. PubMed ID: 21624560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.
    Wiriyasermkul P; Nagamori S; Tominaga H; Oriuchi N; Kaira K; Nakao H; Kitashoji T; Ohgaki R; Tanaka H; Endou H; Endo K; Sakurai H; Kanai Y
    J Nucl Med; 2012 Aug; 53(8):1253-61. PubMed ID: 22743251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).
    Miele E; Spinelli GP; Tomao F; Zullo A; De Marinis F; Pasciuti G; Rossi L; Zoratto F; Tomao S
    J Exp Clin Cancer Res; 2008 Oct; 27(1):52. PubMed ID: 18928537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography radiotracers for imaging hypoxia.
    Wuest M; Wuest F
    J Labelled Comp Radiopharm; 2013; 56(3-4):244-50. PubMed ID: 24285331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.